Neoplasm of Uncertain Malignant Potential: Clinical Trials

6 trials for Neoplasm of Uncertain Malignant Potential, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 31Completed 1

Follow Neoplasm of Uncertain Malignant Potential: new trials by email Literature Review of Neoplasm of Uncertain Malignant Potential trials Research Report on Neoplasm of Uncertain Malignant Potential

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Project: Every Child for Younger Patients With Cancer
Cytology Specimen Collection Procedure, Medical Chart Review - Adrenal Gland Pheochromocytoma, Carcinoma In Situ
RecruitingChildren's Oncology Group750002015-11-032026-08-25
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
clinical observation, infrared photocoagulation therapy - Anal Cancer, Neoplasm of Uncertain Malignant Potential
Phase 3CompletedAIDS Malignancy Consortium1202011-04-012020-08-04
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
DNA methylation analysis, fluorescence in situ hybridization, gene expression analysis - Colorectal Cancer, Neoplasm of Uncertain Malignant Potential
CompletedMemorial Sloan Kettering Cancer Center82007-09-012015-12-23
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
PEG-interferon alfa-2a - Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
Phase 1CompletedNational Institutes of Health Clinical Center (CC)362005-09-012012-03-29
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Cytology Specimen Collection Procedure - Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
CompletedChildren's Oncology Group25452003-10-132018-07-19
Collecting Tumor Samples From Patients With Gynecological Tumors
Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor
CompletedGynecologic Oncology Group2751992-06-012016-10-28

Narrower conditions

Melanoma (2)  ·  Anus Neoplasms (1)  ·  Brenner Tumor (1)  ·  Carcinoma in Situ (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Desmoid Tumors (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ganglioneuroma (1)  ·  Gestational Trophoblastic Disease (1)  ·  HIV Infections (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Immune System Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Urogenital Diseases (3)  ·  Bone Marrow Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Genital Diseases (2)  ·  Hematologic Diseases (2)

Interventions

Biopsy (1)  ·  DNA Methylation (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Gene Expression Profiling (1)  ·  Immunoenzyme Techniques (1)  ·  Immunohistochemistry (1)  ·  In Situ Hybridization, Fluorescence (1)  ·  Light Coagulation (1)  ·  Polymerase Chain Reaction (1)  ·  Reverse Transcriptase Polymerase Chain Reaction (1)  ·  Watchful Waiting (1)  ·  peginterferon alfa-2a (1)

Sponsors

Children's Oncology Group (2)  ·  AIDS Malignancy Consortium (1)  ·  Gynecologic Oncology Group (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Institutes of Health Clinical Center (CC) (1)

Countries

United States (6)  ·  Australia (2)  ·  Canada (2)  ·  New Zealand (2)  ·  Puerto Rico (2)  ·  Saudi Arabia (1)  ·  Switzerland (1)

Top investigators

Brigitte C. Widemann, MD (1)  ·  Douglas S Hawkins (1)  ·  Marc J. Gollub, MD (1)  ·  Michael Cibull (1)  ·  Nilsa Ramirez (1)  ·  Stephen E. Goldstone, MD (1)  ·  Suresh Jhanwar, PhD (1)

Results publications

PMID 21242495, PMID 30060087

NIH funding

U10CA098543 (2), P30CA008748 (1), U01CA121947 (1), U10CA180868 (1), UG1CA189958 (1)